Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology and nephrology, areas of medicine which have significant unmet medical needs.
Our Business Strategy
Our highly experienced Sales and Marketing teams are presently focused on increasing the usage of our primary marketed product, Acthar, among specialists who treat patients with multiple sclerosis, infantile spasms and nephrotic syndrome. In addition, our Medical Affairs personnel are working with leading researchers to explore promising additional uses for this important product in a variety of other conditions.
How we implement our business strategy:
- Increase revenues through sales and marketing activities targeted to physicians who treat patients with serious, difficult-to-treat medical conditions.
- Leverage our primary product, Acthar, through investing in clinical research in patient populations where there is high unmet medical need and potential benefits from Acthar therapy.
- Actively give back to our patients and physician communities by providing state-of-the-art patient assistance programs, as well as financial support for innovative medical research at major academic institutions.